期刊文献+

聚己内酯微孔膜囊管化胰组织及其胰岛素释放的观察 被引量:1

STUDIES ON MICROPOROUS MEMBRANE FORMACROENCAPSULATED PANCREAS
下载PDF
导出
摘要 本文观察了不同孔隙度聚己内酯微孔囊管的通透性,并选择适当孔隙度的微孔囊管包裹大鼠和小鼠胰组织进行体内、外培养。结果表明,聚己内酯微孔囊管能够对胰岛素分子具有良好的通透性,而对免疫球蛋白大分子具有较好的阻挡效果。体外培养显示,囊管化胰组织可对葡萄糖刺激作出较快应答,持续培养三个月,始终有胰岛素释放。体内培养23天后仍能对葡萄糖刺激作出反应。 Microporous membranes were made using biodegradable polycaprolactone with pore-forming material. Experimental results showed that the membrane was permeable for in-sulin and at the same time formed a good barrier to IgG. The tubular membranes (2mm i. d.and 200μpm wall thickness) were filled with mouse pancreas,closed at both ends,and cul-tured in vitro. The insulin was shown released from the macroencapsulated mouse pancreasfor over 2 months and increased in secretion in response to high glucose concentration. Afterplaced in the peritoneal cavity of the pyrimidine-tetraoxide-induced diabetic rats for 23days,the macroencapsulated rat pancreas were removed and exposed to a sequence of low(100mg/dL)and high(300mg/dL) concentration of glucose in the perifusing medium at therate of 2ml/min. The insulin concentration in the perfusate increased from 2. 0±0.8μu/mlto 22.7±4.2μu/ml with in 15 minutes.
出处 《中国生物医学工程学报》 EI CAS CSCD 北大核心 1995年第4期289-291,共3页 Chinese Journal of Biomedical Engineering
关键词 聚己内酯 胶囊 生物人工胰 胰岛素 释放 Polycaprolacton Macrocapsul Bioartificial pancreas
  • 相关文献

参考文献6

二级参考文献2

  • 1施化莲,1990年
  • 2Yie W,1982年

共引文献11

同被引文献14

  • 1唐丽娜,孙洪范,宋存先,冷希岗,崔秀敏,史瑞文.长效抗生育埋植剂CaproF体内药物释放的研究[J].生物医学工程与临床,2007,11(1):17-19. 被引量:6
  • 2Pitt CG, Gratzl MM, Jeffcoat A R, et al. Sustained drug delivery systems II: Factors affecting release rates from poly (epsilon-caprolactone) and related biodegradable polyesters[J]. J Pharm Sci, 1979, 68(12): 1534-1538.
  • 3Mei Lin, Bao Jun-bo, Tang Li-na, et al. A novel mifepristone-loaded implant for long-term treatment of endometriosis: in vitro and in vivo studies[J]. Eur J Pharm Sci, 2010, 39(5): 421-427.
  • 4Sun Hong-fan, Mei Lin, Song Cun-xian, et al. The in vivu degradation, absorption and excretion of PCL-based implant[J]. Biomaterials, 2006, 27(9): 1735-1740.
  • 5Ory SJ, Hammond CB, Yancy SG, et al. The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels[J]. Am J Obstet Gyneeol, 1983, 145(5): 600-605.
  • 6Shin SC, Cho CW. Physieochemical characterizations of piroxicam- poloxamer solid dispersion[J]. Pharm Dev Technol, 1997, 2(4): 403- 407.
  • 7Passerini N, Albertini B, Gonzalez-Rodriguez ML, et al. Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation[J]. Eur J Pharm Sci, 2002, 15(1): 71-78.
  • 8Ma Gui-lei, Song Cun-xian, Sun Hong-fan, et al. A biodegradable levonorgestrel-releasing implant made of PCIJF68 compound as tested in rats and dogs[J]. Contraception, 2006, 74(2): 141-147.
  • 9Ma Gui-Iei, Yang Jing, Zhang Lin-hua, et al. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model[J]. Anticancer Drugs, 2010, 21 (3): 261-269.
  • 10Ma Gui-lei, Song Cun-xian. FCL/poloxamer 188 blend microsphere for paclitaxel delivery: Influence of poloxamer 188 on morphology and drug release[J]. J Appl Polytner Sci, 2007, 104(3): 1895-1899.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部